Paratek Pharmaceuticals, Inc.
PRTKDelisted Sep 21, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001178711
Paratek Pharmaceuticals, Inc. was delisted on Sep 21, 2023; its insiders filed their last Form 4 on Sep 21, 2023; 66 institutions reported holding it in 13F filings for Q2 2023, worth $47.0M in total; no superinvestor held it.
Q2 2023 vs. Q1 2023
How the institutions holding Paratek Pharmaceuticals, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Of which not filed for Q2 2023 | Q2 2023 | Change |
|---|---|---|---|---|
| Holders | 63 | 1 | 66 | +4 |
| Shares | 23.3M | 18.3K | 21.2M | −2.04M (−8.8%) |
| Value | $59.1M | $46.6K | $47.0M | −$12.0M (−20.3%) |
1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (21)
Institutions that held Paratek Pharmaceuticals, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Newtyn Management, LLC | 764,274 | $1.69M | 0.40% |
| Natixis | 491,724 | $1.09M | 0.01% |
| Polar Asset Management Partners Inc. | 479,504 | $1.06M | 0.02% |
| Hunting Hill Global Capital, LLC | 361,226 | $798.3K | 0.48% |
| PenderFund Capital Management Ltd. | 233,590 | $684.0K | 0.21% |
| Gabelli & Co Investment Advisers, Inc. | 306,950 | $678.4K | 0.11% |
| Fifth Lane Capital, LP | 261,781 | $578.5K | 0.56% |
| Yakira Capital Management, Inc. | 100,000 | $221.0K | 0.06% |
| Equitec Proprietary Markets, LLC | 95,600 | $211.3K | 0.15% |
| Deltec Asset Management LLC | 70,468 | $155.7K | 0.03% |
| Alpine Global Management, LLC | 66,402 | $146.7K | 0.04% |
| XTX Topco Ltd | 62,938 | $139.1K | 0.02% |
| Deuterium Capital Management, LLC | 55,136 | $121.9K | 0.17% |
| GTS Securities LLC | 22,000 | $48.6K | 0.00% |
| Two Sigma Securities, LLC | 19,521 | $43.1K | 0.00% |
| CSS LLC | 14,000 | $30.9K | 0.00% |
| Covestor Ltd | 11,184 | $25.0K | 0.02% |
| Rhumbline Advisers | 1,112 | $2.46K | 0.00% |
| Parallel Advisors, LLC | 750 | $1.66K | 0.00% |
| Tower Research Capital LLC (TRC) | 100 | $221 | 0.00% |
| Simplex Trading, LLC | 22 | $0 | 0.00% |
Sold out (17)
Institutions that held Paratek Pharmaceuticals, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| AIGH Capital Management LLC | 2,674,812 | $6.79M |
| Omega Fund Management, LLC | 1,971,241 | $5.01M |
| Worth Venture Partners, LLC | 657,885 | $1.67M |
| Assenagon Asset Management S.A. | 368,240 | $935.3K |
| Acadian Asset Management LLC | 139,386 | $352.0K |
| Bridgeway Capital Management, LLC | 107,700 | $273.6K |
| Millennium Management LLC | 71,470 | $182.0K |
| Goldman Sachs Group Inc | 36,773 | $93.4K |
| Group One Trading, L.P. | 33,812 | $85.9K |
| Virtu Financial LLC | 18,192 | $46.0K |
| Invesco Ltd. | 16,051 | $40.8K |
| Arete Wealth Advisors, LLC | 14,050 | $36.0K |
| Schonfeld Strategic Advisors LLC | 13,900 | $35.3K |
| Qube Research & Technologies Ltd | 12,028 | $30.6K |
| Cutter & CO Brokerage, Inc. | 10,900 | $27.7K |
| Baader Bank INC | 11,580 | $22.9K |
| Northwestern Mutual Wealth Management Co | 100 | $254 |
Not filed for Q2 2023 yet (1)
Institutions that held Paratek Pharmaceuticals, Inc. at the end of Q1 2023 and haven't filed a 13F for Q2 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| ETF Managers Group, LLC | 18,339 | $46.6K |